University of Florida Research Foundation Inc

Torrey Pines Institute for Molecular Studies

Christopher R Cogle

Douglas Grant McFadden

Eric C Bartee

Richard Allen Houghten

Marcello Angelo Giulianotti

Peter P Sayeski

Gregory S Welmaker

Amy M Meacham

Douglas Grant Mcfadden

Eric Carter Bartee

Cancer is a disease for which there remains a great unmet medical need, and therefore the discovery and development of new antineoplastic agents is critically important. The present invention relates in part to new therapeutic compounds with antineoplastic activity. Provided herein are polyamine sulfonamides such as compounds of Formula (I), or pharmaceutically acceptable salts thereof, which may be used in the treatment and/or prevention of diseases such as cancer. Also provided herein are pharmaceutical compositions and kits comprising the inventive compounds. Furthermore, the present invention provides methods of treating and/or preventing diseases (e.g., cancer) using compounds of Formula (I), or pharmaceutically acceptable salts thereof or pharmaceutical compositions thereof. Other methods provided include methods for inducing apoptosis of a cell, as well as methods for inhibiting alpha-enolase enzymatic activity in vivo and in vitro.

Polyamine sulfonamides and uses thereof

A method of treating or preventing graft versus host disease (GVHD) in a subject receiving a graft comprising hematopoietic cells is provided. The method comprises contacting the graft ex vivo with an amount of a Myxoma Virus effective to inhibit proliferation of T lymphocytes in the graft and to treat or prevent GVHD in the host subject following infusion of the graft into the subject. After the contacting of the graft with the Myxoma Virus, the method comprises transplanting the virus-treated graft into the subject.

Myxoma-treated graft material for cancer treatment

Method for treating or preventing graft versus host disease

Growing community of inventors

Gainesville, FL, United States of America

Christopher R Cogle